The estimated Net Worth of Harland Cecil Stonecipher is at least $45.3 Million dollars as of 15 September 2010. Harland Stonecipher owns over 14,119 units of PPD Inc stock worth over $38,654,142 and over the last 21 years Harland sold PPD stock worth over $6,611,306.
Harland has made over 13 trades of the PPD Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Harland sold 14,119 units of PPD stock worth $850,670 on 15 September 2010.
The largest trade Harland's ever made was exercising 100,000 units of PPD Inc stock on 25 April 2007 worth over $2,420,000. On average, Harland trades about 15,990 units every 70 days since 2003. As of 15 September 2010 Harland still owns at least 817,558 units of PPD Inc stock.
You can see the complete history of Harland Stonecipher stock trades at the bottom of the page.
Harland's mailing address filed with the SEC is RURAL ROUTE 1, , CENTRAHOMA, OK, 74534-9801.
Over the last 21 years, insiders at PPD Inc have traded over $14,532,346,241 worth of PPD Inc stock and bought 130,455 units worth $3,520,800 . The most active insiders traders include Corporate Investors Viii, L..., Corporate Investors Vii, Lt..., and Group Management L.L.C.Carl.... On average, PPD Inc executives and independent directors trade stock every 53 days with the average trade being worth of $124,899,671. The most recent stock trade was executed by Corporate Investors Viii, L... on 8 December 2021, trading 132,841,266 units of PPD stock currently worth $6,309,960,135.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.
PPD Inc executives and other stock owners filed with the SEC include: